NANOCELA Trademark

Trademark Overview

On Monday, October 29, 2018, a trademark application was filed for NANOCELA with the United States Patent and Trademark Office. The USPTO has given the NANOCELA trademark a serial number of 88173542. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 20, 2022. This trademark is owned by Sun Pharma Global FZE. The NANOCELA trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals
nanocela

General Information

Serial Number88173542
Word MarkNANOCELA
Filing DateMonday, October 29, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 20, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 19, 2019

Trademark Statements

Goods and ServicesDrug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 13, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSUN PHARMACEUTICAL INDUSTRIES LIMITED
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressVADODARA, GUJARAT 390012
IN
Party NameSun Pharma Global FZE
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDubai
AE
Party NameSun Pharma Global FZE
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDubai
AE

Trademark Events

Event DateEvent Description
Wednesday, September 7, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 21, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 20, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, November 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 18, 2021SOU EXTENSION 5 GRANTED
Thursday, November 11, 2021SOU EXTENSION 5 FILED
Thursday, November 18, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 11, 2021TEAS EXTENSION RECEIVED
Saturday, May 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 13, 2021SOU EXTENSION 4 GRANTED
Thursday, May 13, 2021SOU EXTENSION 4 FILED
Thursday, May 13, 2021TEAS EXTENSION RECEIVED
Friday, November 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 11, 2020SOU EXTENSION 3 GRANTED
Wednesday, November 11, 2020SOU EXTENSION 3 FILED
Wednesday, November 11, 2020TEAS EXTENSION RECEIVED
Friday, May 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 13, 2020SOU EXTENSION 2 GRANTED
Wednesday, May 13, 2020SOU EXTENSION 2 FILED
Wednesday, May 13, 2020TEAS EXTENSION RECEIVED
Friday, November 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 13, 2019SOU EXTENSION 1 GRANTED
Wednesday, November 13, 2019SOU EXTENSION 1 FILED
Wednesday, November 13, 2019TEAS EXTENSION RECEIVED
Tuesday, May 14, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 4, 2019ASSIGNED TO EXAMINER
Tuesday, November 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 1, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

nanocela delivery facilitate pharmaceuticals compounds consisting agents drug